Flow Cytometry in Oncology and Immunology Market: Future Growth and Opportunities Revealed by Techsci Research

According to TechSci Research report, “Flow Cytometry in Oncology and Immunology Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028,” the Global Flow Cytometry in Oncology and Immunology Market is likely to register an impressive CAGR in the forecast period, 2024-2028 on account of rising prevalence of cancer cases.

Flow cytometry (FCM) is a multi-parameter analytical laboratory test for the characterization of single cells and has been widely used in preclinical as well as in clinical cancer immunotherapy studies. FCM is a technique of measuring the number and characteristics of single cell that are flowing through a detector system, using a fluorochrome-labeled monoclonal antibody.

However, stringent regulatory scenario related to high cost of the products of the flow cytometry equipment, false antibody responses and the lack of awareness slows down the market growth in the coming years. Also, lack of skilled professionals to conduct sensitive surgeries/therapies can further slowdown the market growth.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Flow Cytometry in Oncology and Immunology Market”- https://www.techsciresearch.com/report/flow-cytometry-in-oncology-and-immunology-market/15020.html

Global Flow Cytometry in Oncology and Immunology Market can be segmented into type, technology, offering, application, end user, region, and company. Based on type, the market can be segmented into immunology, oncology. The segment oncology is expected to show an impressive growth in the forecast period due to rising prevalence of cancer.

Based on technology, the market can be segmented into cell-based flow cytometry, bead-based flow cytometry. The segment cell-based flow cytometry shows an impressive growth in the future due to rapid advancement in therapies for single cells.

Based on application, the market can be segmented into translational research and clinical research. The segment translational research is expected to show an impressive growth in the forecast period due to recent scientific discoveries.

The leading companies operating in the global flow cytometry in oncology and immunology market are:

• Danaher Corporation
• Merck KGaA
• Miltenyi Biotec
• Neo-Genomics Laboratories, Inc.
• Thermo Fisher Scientific Inc
• Cell Signaling Technology, Inc
• Becton, Dickinson and Company
• Agilent Technologies, Inc.
• DiaSorin S.p.A (Luminex Corporation)
• OPKO Health, Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“North America is expected to dominate the global flow cytometry in oncology and immunology market during the forecast period on account of rising prevalence of cancer cases, recent development, and product launches. Additionally, high market penetration rate of technologically advanced immune-oncology therapies is expected to increase the demand for flow cytometry in oncology and immunology market in the coming years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Flow Cytometry in Oncology and Immunology Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Type (Immunology, Oncology), By Technology (Cell-Based Flow Cytometry, Bead-Based Flow Cytometry), By Offering (Reagents, Instruments, and Consumables Software), By Application (Translational Research, Clinical Research), By End User (Hospitals, Diagnostic Laboratories, and Reference Laboratories, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others), By Region,” has evaluated the future growth potential of Global Flow Cytometry in Oncology and Immunology Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Flow Cytometry in Oncology and Immunology Market.

Download Free Sample Report- https://www.techsciresearch.com/sample-report.aspx?cid=15020

Related Reports :

Saudi arabia in vitro fertilization market

Genetic engineering tool market

Radiomics market

Marine biotechnology market

About TechSci Research:

TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Web: https://www.techsciresearch.com